声明称，同仁堂已派专项工作组赴四川核查涉事产品，责令涉事经销主体下架产品并依法赔偿消费者， 同时依法追究四川健康、哈博药业及相关电商平台的商标侵权等责任。此外，为进一步保护消费者权 益，强化品牌保护责任，同仁堂集团还将开展品牌使用拉网式排查、清理"擦边"字号及不规范商标使用 行为，并规范电商平台授权店铺标识，引导消费者识别正规渠道。 北京商报讯（记者 王寅浩 宋雨盈）12月20日，北京同仁堂集团发布声明，就"南极磷虾油"事件引发的 消费者权益损害问题致歉，并宣布开展品牌严管专项行动。 ...

来源 | 北京同仁堂官微 中国北京同仁堂（集团）有限责任公司12月20日发布声明： 针对近日有关"南极磷虾油"的舆论关注，北京同仁堂集团高度重视、深感痛心，对因此给消费者造成的 权益损害，向广大消费者和社会各界致以最诚恳的歉意！同仁堂集团立即开展零容忍品牌严管专项行 动，已采取如下措施： 一、派专项工作组到四川，对涉事产品开展全面深入核查，坚决一查到底。 四、对四川健康及其控股股东健康药业等单位在经营、管理、监督环节存在的问题开展问责，严肃追究 相关人员责任。 为进一步保护消费者权益，强化品牌保护责任，同仁堂集团同时开展以下工作： 一、全面排查品牌使用中的违法违规行为，对集团各级企业的品牌使用情况进行拉网式核查。 二、全面开展品牌清理行动，坚决清理"擦边"使用"同仁堂"字号、商标使用不规范等行为，严格规范品 牌管理体系。 三、全面规范电商平台授权店铺标识，严格使用"同仁堂"双龙图案商标，主动引导消费者准确识别正规 购买渠道。 "同仁堂"品牌创立356年来，始终离不开广大消费者的支持和厚爱。我们心怀感恩，诚恳接受社会各界 的监督与批评，愿意与大家一道，共同守护好"同仁堂"金字招牌，以实际行动维护"同仁堂"的品牌 ...

Core Viewpoint - Beijing Tongrentang Group issued an apology regarding the Antarctic krill oil incident, emphasizing a zero-tolerance policy towards brand management and consumer protection [1][2]. Group 1: Company Actions - The company has initiated a special task force to conduct a thorough investigation of the involved products in Sichuan, ensuring a comprehensive inquiry [2]. - The company has ordered the immediate removal of the implicated products from the market and is supervising compliance with regulatory requirements for consumer compensation [2]. - Legal actions will be pursued against Sichuan Health, Habao Pharmaceutical, and related e-commerce platforms for trademark infringement and misleading consumers [2][3]. Group 2: Brand Protection Measures - The company is conducting a comprehensive review of brand usage to identify any illegal or non-compliant practices across its subsidiaries [2]. - A brand cleanup initiative is underway to eliminate improper use of the "Tongrentang" name and ensure strict adherence to brand management standards [2]. - The company is standardizing e-commerce platform store identifiers to ensure the correct use of the "Tongrentang" double-dragon logo, guiding consumers to recognize legitimate purchasing channels [3]. Group 3: Incident Background - A product labeled as "Beijing Tongrentang 99% High Purity Antarctic Krill Oil" was found to falsely claim high phospholipid content, with testing revealing a phospholipid content of 0% [3]. - The implicated product was produced by Anhui Habao Pharmaceutical Co., Ltd., and distributed by Sichuan Tongrentang Health Pharmaceutical Co., Ltd., which is a subsidiary of Beijing Tongrentang Group [3][7]. - The company clarified that Sichuan Tongrentang Health Pharmaceutical is not a direct subsidiary of Beijing Tongrentang but is under the control of its parent company [7].

四、对四川健康及其控股股东健康药业等单位在经营、管理、监督环节存在的问题开展问责，严肃追究 相关人员责任。 为进一步保护消费者权益，强化品牌保护责任，同仁堂集团同时开展以下工作： 一、全面排查品牌使用中的违法违规行为，对集团各级企业的品牌使用情况进行拉网式核查。 二、全面开展品牌清理行动，坚决清理"擦边"使用"同仁堂"字号、商标使用不规范等行为，严格规范品 牌管理体系。 12月20日，北京同仁堂集团发表声明： 针对近日有关"南极磷虾油"的舆论关注，北京同仁堂集团高度重视、深感痛心，对因此给消费者造成的 权益损害，向广大消费者和社会各界致以最诚恳的歉意！同仁堂集团立即开展零容忍品牌严管专项行 动，已采取如下措施： 一、派专项工作组到四川，对涉事产品开展全面深入核查，坚决一查到底。 二、责令并监督涉事经销主体四川健康立即下架涉事产品，严格按照监管部门要求依法依规对消费者进 行赔偿。 三、依法追究四川健康、哈博药业及相关电商平台的商标侵权等责任。对其违法使用"北京同仁堂"字 样，误导消费者判断，损害消费者合法权益的行为追究法律责任。 （文章来源：上海证券报） 三、全面规范电商平台授权店铺标识，严格使用"同仁堂"双龙 ...

Core Viewpoint - Beijing Tongrentang Group issued an apology regarding the Antarctic krill oil incident, emphasizing a zero-tolerance policy towards brand management and consumer protection [2][3]. Group 1: Actions Taken by the Company - A special task force has been dispatched to Sichuan to conduct a thorough investigation of the involved products [3]. - The company has ordered the immediate removal of the implicated products from the market and will ensure compensation to consumers as per regulatory requirements [4]. - Legal actions will be pursued against Sichuan Health, Habao Pharmaceutical, and related e-commerce platforms for trademark infringement and misleading consumers [4]. - Accountability measures will be implemented for Sichuan Health and its parent company regarding operational and management issues [4]. Group 2: Brand Protection Initiatives - A comprehensive review of brand usage violations across all subsidiaries will be conducted [5]. - A brand cleanup initiative will be launched to eliminate improper use of the "Tongrentang" name and ensure compliance with brand management standards [6]. - E-commerce platform stores will be required to strictly use the "Tongrentang" double-dragon logo to help consumers identify legitimate purchasing channels [7]. Group 3: Incident Background - A product labeled as "Beijing Tongrentang 99% High Purity Antarctic Krill Oil" was found to falsely claim high phospholipid content, with actual testing revealing a phospholipid content of 0% [7]. - The implicated product was produced by Anhui Habao Pharmaceutical and distributed by Sichuan Tongrentang Health, which is not a direct subsidiary of Beijing Tongrentang [7][10]. - The company clarified that it focuses on the production and sale of traditional Chinese medicine, with over 400 product specifications, and does not outsource production to third parties [10].

Core Viewpoint - Beijing Tongrentang Group has issued an apology regarding the recent controversy surrounding "Antarctic krill oil," acknowledging the damage to consumer rights and emphasizing their commitment to consumer protection and brand integrity [1][3]. Group 1: Company Response - The company has initiated a zero-tolerance brand management action, including a comprehensive investigation into the involved products and the immediate removal of the products from the market [2]. - Legal actions will be pursued against the involved parties, including Sichuan Health and Harbo Pharmaceutical, for trademark infringement and misleading consumers [2][3]. - The company will conduct a thorough review of brand usage across its subsidiaries to eliminate any unauthorized or misleading use of the "Tongrentang" brand [3]. Group 2: Product Controversy - A product labeled as "99% high-purity Antarctic krill oil" was found to have a phospholipid content of 0%, despite claims of 43%, raising concerns of false advertising [10][14]. - The product in question is produced by Anhui Harbo Pharmaceutical and distributed by Beijing Tongrentang (Sichuan) Health Pharmaceutical, which is a subsidiary of Tongrentang Group [14]. - The Shanghai Consumer Protection Committee is taking action to address the alleged fraudulent behavior and protect consumer rights [10][14]. Group 3: Industry Context - Antarctic krill oil is marketed for its health benefits, including brain function improvement and immune enhancement, leading to its popularity in the market [8]. - The production methods of krill oil can vary, affecting phospholipid content, but any discrepancies between advertised and actual content can lead to consumer trust issues [12][13][14]. - The practice of allowing subsidiaries to use the main brand's trademark can reduce costs and increase revenue but may dilute brand value if not managed properly [14].

Group 1 - The core viewpoint of the article is that Beijing Tongrentang Group is taking immediate and serious actions in response to recent public concerns regarding "Antarctic krill oil," expressing deep regret for the harm caused to consumers and committing to protect consumer rights [1][2] - The company has initiated a zero-tolerance brand management action, which includes a comprehensive investigation into the involved products and parties, specifically targeting the distributor Sichuan Health [1] - Measures taken include ordering the immediate removal of the implicated products from shelves, ensuring legal compensation for consumers, and pursuing legal accountability for trademark infringement against Sichuan Health, Habao Pharmaceutical, and related e-commerce platforms [1][2] Group 2 - To further protect consumer rights and strengthen brand protection responsibilities, the company is conducting a thorough investigation into illegal and irregular brand usage across its enterprises [2] - A brand cleanup initiative is being launched to eliminate improper use of the "Tongrentang" name and trademark, thereby enforcing a strict brand management system [2] - The company is also standardizing the branding of authorized e-commerce store logos to ensure the correct use of the "Tongrentang" double-dragon logo, guiding consumers to accurately identify legitimate purchasing channels [2]

Core Viewpoint - Tong Ren Tang Group publicly apologized for the recent controversy surrounding its Antarctic krill oil product, acknowledging the damage caused to consumer rights and committing to a thorough brand management initiative [1][3]. Group 1: Company Response - The company has initiated a zero-tolerance brand management action, deploying a special task force to Sichuan for a comprehensive investigation of the involved products [3]. - The company has ordered the immediate removal of the implicated products from the market and is ensuring compliance with regulatory requirements for consumer compensation [4]. - Legal actions will be pursued against the involved parties, including Sichuan Health and Habao Pharmaceutical, for trademark infringement and misleading consumers [4]. Group 2: Brand Protection Measures - To further protect consumer rights, the company will conduct a thorough review of brand usage for any illegal or non-compliant activities and implement a comprehensive brand cleanup initiative [5]. - The company aims to standardize the use of its trademarks and ensure that consumers can accurately identify legitimate purchasing channels [5]. Group 3: Background Information - Tong Ren Tang brand was established in 1669, and the group was formed in 1992, transitioning to a state-owned enterprise in 2001 [8]. - The company has multiple subsidiaries, with Tong Ren Tang Health, established in April 2023, being one of its strategic branches in the health sector [8]. - As of December 19, the A-share price of Tong Ren Tang was 32.42 yuan per share, with a total market capitalization of 44.5 billion yuan [8].

Core Viewpoint - Beijing Tongrentang Group has issued an apology regarding consumer rights damage caused by recent controversies surrounding "Antarctic Krill Oil" and has initiated a zero-tolerance brand management action [1][3][5]. Group 1: Actions Taken by the Company - A special task force has been dispatched to Sichuan to conduct a thorough investigation of the involved products [1][3][5]. - The company has ordered and is supervising the immediate removal of the implicated products from the market by the distributor, Sichuan Health, and will ensure compensation for consumers as per regulatory requirements [1][3][5]. - Legal actions will be pursued against Sichuan Health, Habao Pharmaceutical, and related e-commerce platforms for trademark infringement and misleading consumers [1][3][5]. Group 2: Brand Protection Measures - The company is conducting a comprehensive review of illegal and irregular brand usage across all levels of its enterprises [2][6]. - A brand cleaning initiative is being implemented to eliminate improper use of the "Tongrentang" name and ensure compliance with brand management standards [2][6]. - The company is standardizing the branding of authorized e-commerce store signs to ensure the correct use of the "Tongrentang" double-dragon logo and guide consumers to recognize legitimate purchasing channels [2][6].

Group 1 - Beijing Tongrentang Group has initiated a special action to strictly manage its brand in response to recent public concerns regarding "Antarctic krill oil" [1][2] - The company has dispatched a special task force to Sichuan to conduct a thorough investigation of the involved products and ensure accountability [1] - Measures include ordering the immediate removal of the implicated products from the market and pursuing legal action against entities misusing the "Beijing Tongrentang" trademark [1] Group 2 - The company is committed to protecting consumer rights and has launched a comprehensive review of brand usage across its enterprises to identify any illegal or irregular practices [1][2] - A brand cleaning initiative is underway to eliminate improper use of the "Tongrentang" name and ensure compliance with brand management standards [1] - The company expresses gratitude to consumers for their support over its 356-year history and welcomes public supervision and criticism to maintain its brand reputation [2]